Pharmacology - Wan Lab

Fingerprint Dive into the research topics where Pharmacology - Wan Lab is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Osteogenesis Medicine & Life Sciences
Osteoclasts Medicine & Life Sciences
Peroxisome Proliferator-Activated Receptors Medicine & Life Sciences
rosiglitazone Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Bone Resorption Medicine & Life Sciences
Bone Remodeling Medicine & Life Sciences
Bone Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Yihong Wan
19972019

Research Output 1997 2019

Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Nature, (2014), 512, 7515, (431-435), 10.1038/nature13375)

Krzeszinski, J. Y., Wei, W., Huynh, H. D., Jin, Z., Wang, X., Chang, T-C., Xie, X-J., He, L., Mangala, L. S., Lopez-Berestein, G., Sood, A. K., Mendell, J. T. & Wan, Y., Jan 1 2019, In : Nature.

Research output: Contribution to journalComment/debate

Open Access
Osteogenesis
Osteoporosis
Neoplasm Metastasis
Bone and Bones

NR Supplementation During Lactation: Benefiting Mother and Child

Yang, D. & Wan, Y., Jan 1 2019, In : Trends in Endocrinology and Metabolism.

Research output: Contribution to journalShort survey

Lactation
NAD
Mothers
Postpartum Period
Homeostasis
7 Citations (Scopus)

mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1

Huynh, H. D. & Wan, Y., Dec 1 2018, In : Communications Biology. 1, 1, 29.

Research output: Contribution to journalArticle

Open Access
osteoclasts
Calcineurin
Osteoclasts
Bone
bones